Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1046/j.1464-410x.1999.00198.x | DOI Listing |
Head Neck Pathol
June 2024
Division of Dental and Oral Medicine, New York-Presbyterian/Queens, Flushing, New York, USA.
Ophthalmic Plast Reconstr Surg
July 2024
Department of Pathology, Bangalore Medical College and Research Institute, India.
Clin Nucl Med
October 2023
Department of Nuclear Medicine, Peking University First Hospital, Beijing, China.
A 56-year-old man presented with a 2-month history of a mass in the right epididymo-testicular region, which exhibited heterogeneous high avidity for 18F-FDG on PET/CT. Malignant tumor was highly suspected, leading to subsequent right orchiectomy and epididymectomy. Histopathological examination revealed the presence of characteristic Michaelis-Gutmann bodies within von Hansemann macrophages, confirming the diagnosis of malacoplakia.
View Article and Find Full Text PDFJ Comp Pathol
August 2023
Department of Animal Pathology, University of Zaragoza, 177 Miguel Servet Street, 50013 Zaragoza, Spain.
Malakoplakia is a rare chronic granulomatous disease usually affecting the urinary bladder and other locations. In humans, the gastrointestinal tract is the second most common location but there are no reports of intestinal malakoplakia in animals. A 10-month-old female French Bulldog was presented with chronic haemorrhagic diarrhoea and anorexia with normochromic-normocytic anaemia and hypoalbuminaemia.
View Article and Find Full Text PDFDiagn Pathol
August 2023
Department of Laboratory Medicine, Panyu District Central Hospital, Guangzhou, China.
Background: Malakoplakia is a rare inflammatory disease of the urogenital tract. There have been no reports of malakoplakia expressing anaplastic lymphoma kinase (ALK) to date. Here, we present one case of malakoplakia with aberrant ALK expression by immunohistochemistry and discuss the clinical significance.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!